Akari Therapeutics, Plc (AKTX)

NASDAQ: AKTX · Real-Time Price · USD

15.07

-0.77 (-4.86%)

At close: Jun 5, 2026, 4:00 PM EDT

15.50

+0.43 (2.85%)

After-hours: Jun 5, 2026, 7:36 PM EDT

Akari Therapeutics, Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	17	13	32	18	35	71
Market Cap Growth	-56.77%	-59.03%	83.11%	-49.58%	-51.00%	0.31%
Enterprise Value	15	13	31	10	27	58
Last Close Price	15.07	11.56	48.80	124.80	375.92	1200.00
PB Ratio	1.20	0.47	1.45	-77.02	19.53	12.85
P/TBV Ratio	-	-	-	-	19.72	12.91
Debt / Equity Ratio	0.05	0.03	0.15	-	-	-
Net Debt / Equity Ratio	-0.14	-0.16	0.03	16.79	-7.40	-1.68
Net Debt / EBITDA Ratio	-	0.37	-0.04	0.23	0.57	0.54
Net Debt / FCF Ratio	0.19	0.42	-0.05	0.23	0.62	0.50
Quick Ratio	0.21	0.42	0.13	0.84	1.10	1.54
Current Ratio	0.27	0.44	0.15	0.95	1.15	1.91
Return on Equity (ROE)	-155.28%	-68.43%	-179.92%	-1281.43%	-483.23%	-233.27%
Return on Assets (ROA)	-17.97%	-15.36%	-37.89%	-115.51%	-113.26%	-81.96%
Return on Capital Employed (ROCE)	-59.60%	-34.00%	-54.30%	7338.90%	-1289.10%	-309.90%
Earnings Yield	-162.61%	-130.73%	-61.28%	-56.74%	-50.73%	-24.40%
FCF Yield	-63.23%	-79.87%	-38.87%	-93.17%	-61.47%	-26.40%
Buyback Yield / Dilution	-143.97%	-181.85%	-144.03%	-56.79%	-45.46%	-35.87%

SEC Filings: 10-K · 10-Q